Showing results (81-90 of 168) with videos related to
Sort By:
Pageof 17
Movement Disorders Clinical Practice|August 18, 2021
Ondine's Curse in Frontotemporal Dementia with Parkinsonism Linked to Chromosome 17 Caused by <i>MAPT</i> VariantsLaura Williams, Diana A Olszewska, Conor Fearon, et al.Journal of Neurology|January 3, 2021
Biochemical markers for severity and risk in GBA and LRRK2 Parkinson's diseaseAvner Thaler, Nurit Omer, Nir Giladi, et al.Annals of Neurology|July 12, 2002
Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trialIra Shoulson, David Oakes, Stanley Fahn, et al.The Lancet. Neurology|January 12, 2010
Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysisChris C Tang, Kathleen L Poston, Thomas Eckert, et al.Movement Disorders : Official Journal of the Movement Disorder Society|February 2, 2006
Rasagiline improves quality of life in patients with early Parkinson's diseaseKevin M Biglan, Steven Schwid, Shirley Eberly, et al.Archives of Neurology|June 24, 2004
Reaction time and movement time after embryonic cell implantation in Parkinson diseasePaul H Gordon, Qiping Yu, Clifford Qualls, et al.Archives of Neurology|March 16, 2005
Contribution of aging to the severity of different motor signs in Parkinson diseaseGilberto Levy, Elan D Louis, Lucien Cote, et al.Archives of Neurology|July 21, 2004
Lack of familial aggregation of Parkinson disease and Alzheimer diseaseGilberto Levy, Elan D Louis, Helen Mejia-Santana, et al.Scientific Reports|June 11, 2020
Metabolic syndrome does not influence the phenotype of LRRK2 and GBA related Parkinson's diseaseAvner Thaler, Shani Shenhar-Tsarfaty, Yanay Shaked, et al.Annals of Neurology|October 2, 2003
Familial aggregation of early- and late-onset Parkinson's diseaseKaren Marder, Gilberto Levy, Elan D Louis, et al.Pageof 17